<?xml version="1.0" encoding="UTF-8"?>
<p>NF-κB and AP-1 also directly regulate HO-1 expression as transcription factors. Unlike evolutionary conserved Nrf2-HO-1 regulation, the HO-1 regulation by NF-κB and AP-1 is dependent on lipopolysaccharide (LPS), a prototypical Toll-like receptor 4 (TLR4) agonist [
 <xref rid="B77-antioxidants-09-01191" ref-type="bibr">77</xref>]. Once TLR4 is stimulated by LPS or monophosphoryl lipid A, another synthetic TLR4 agonist, it activates NF-κB [
 <xref rid="B78-antioxidants-09-01191" ref-type="bibr">78</xref>,
 <xref rid="B79-antioxidants-09-01191" ref-type="bibr">79</xref>] and AP-1 [
 <xref rid="B80-antioxidants-09-01191" ref-type="bibr">80</xref>]. Inhibition of the NF-κB pathway with small molecules suppressed LPS-induced HO-1 promoter activity [
 <xref rid="B77-antioxidants-09-01191" ref-type="bibr">77</xref>]. AP-1 homodimers or heterodimers bind to enhancers of the promoter region of 
 <italic>hmox1</italic> [
 <xref rid="B81-antioxidants-09-01191" ref-type="bibr">81</xref>]. The expression of HO-1 requires AP-1 activation by LPS [
 <xref rid="B80-antioxidants-09-01191" ref-type="bibr">80</xref>].
</p>
